Crypto market cap $2.14 T −4.25%24h volume $85.6 BBTC dominance 58.0%Fear & Greed 12/100BTC $62,043.90 −2.56%ETH $1,756.69 −2.65%S&P 500 (SPY) $715.87 −1.96%Gold $3,580.40 −2.85%Updated 2026-11-20
★ 💼

Novartis (NOVN): price, chart and what’s happening

NOVN Stock
$152.42+0.91%Local price: 128.40 CHF

If you had bought $10 of Novartis every day since November 2021, you would have put in $18,260 and it would be worth $29,410 today (+61.1%). Change the amount, frequency or start date and compare with other assets.

Live chart · NOVN

LiveTradingView ↗

Key numbers · NOVN

Market cap$285.41 B#44 in the world by market cap
1 year+20.7%
P/E (price / earnings)30.6
Dividend2.88%
Revenue (12 months)$57.36 B+4.70%
Net income$10.03 BProfit margin: 17.5%
Volatility (beta)0.45calmer than the market
Employees75,267
SectorHealthcare
52-week range
low $117.91high $162.43
Analysts · 22holdAverage price target: $152.55 (+0.08%)

In plain words

Novartis (NOVN) is a company in the Healthcare sector, based in Switzerland. The company is worth $285.41 B on the stock market. Revenue over the last year was $57.36 B (+4.70% vs the year before). It is profitable: out of every $100 of revenue, $17.49 is left as net profit. The share costs about 31 years of the company’s earnings (P/E). The price is 6.16% below its 52-week high and 29.3% above its 52-week low. It pays a dividend of about 2.88% of the share price a year. 22 analysts on average rate it “hold” with a price target of $152.55 (+0.08% from today).

Data: Yahoo Finance, updated 2026-11-20. Prices in USD at the current rate. Analyst ratings are opinions, not guarantees. Not investment advice.

Markets daily on TelegramWhat moves crypto, stocks and gold — short, with real numbers.Join channel
DCA $10/day · 1 year
$3,712
+1.71% · invested $3,650
DCA $10/day · 3 years
$14,485
+32.2% · invested $10,960
DCA $10/day · 5 years
$29,410
+61.1% · invested $18,260
DCA $10/day · 10 years
$78,457
+115% · invested $36,520
$1,000 1 year ago
$1,207
+20.7%
$1,000 3 years ago
$1,733
+73.3%
$1,000 5 years ago
$2,444
+144%
$1,000 10 years ago
$3,880
+288%

What is Novartis (NOVN)?

Novartis is a Basel-based maker of prescription medicines — from the breast-cancer drug Kisqali to the heart pill Entresto — and one of the two giants, with Roche, that make Switzerland's stock market a pharma market.

How it makes money

Novartis researches new medicines, wins patents and sells the drugs to hospitals, insurers and health systems worldwide. In 2025 it sold $54.5 billion (+8%) and earned $14.0 billion in net profit, keeping about 40 cents of every dollar of sales as core operating profit. Its biggest products are Entresto (heart failure, $7.7 billion in 2025), Cosentyx (psoriasis and arthritis, $6.7 billion), Kisqali ($4.8 billion, +58%) and Kesimpta (multiple sclerosis, $4.4 billion).

The company was born in 1996 from the merger of Ciba-Geigy and Sandoz. It later spun off its eye-care unit Alcon (2019) and its generics arm Sandoz (2023), so today it is a pure "innovative medicines" company.

Why it matters

Novartis is one of the heaviest stocks in the Swiss SMI index and a classic dividend payer: for 2025 it proposed CHF 3.70 per share, its 29th increase in a row since it was created. One surprising fact: in the third quarter of 2026 Entresto sales fell 38% after US generics arrived — yet total sales still grew 4%, carried by Kisqali (+37%) and the cholesterol shot Leqvio (+63%).

Key numbers

  • Price today: $152.42
  • $10 a day for 5 years: $29,410 from $18,260 invested (+61.1%)
  • $10 a day for 10 years: $78,457 from $36,520 invested (+115%)

See more of the market on the Swiss stocks page.

Main risks

Patents expire: every blockbuster eventually faces cheaper copies, and new drugs must replace the lost sales. Research is risky — in Q3 2026 Novartis wrote down $1.9 billion on one experimental drug. US drug-price pressure and tariffs hit all big pharma. Prices on our site are in US dollars, so the Swiss franc also moves the return. Buying a fixed amount regularly smooths price swings but does not remove the risk.

Not investment advice.

Sources

Novartis (NOVN): returns by month

$

Portfolio value over time

Technical analysis · NOVN

News · NOVN

Fundamentals · NOVN

$10 a day in Novartis: results by period

PeriodInvestedNowResult
1 year$3,650$3,712+1.71%
3 years$10,960$14,485+32.2%
5 years$18,260$29,410+61.1%
10 years$36,520$78,457+115%
Since Jan 2000$98,210$517,196+427%

FAQ

What does Novartis do?

Novartis (NOVN) is a company in the Healthcare sector, based in Switzerland. The company is worth $285.41 B on the stock market. Revenue over the last year was $57.36 B (+4.70% vs the year before).

What would $1,000 invested in Novartis 5 years ago be worth today?

A one-time $1,000 investment in Novartis 5 years ago would be worth $2,444 today (+144%).

Does Novartis pay a dividend?

It pays a dividend of about 2.88% of the share price a year.

What is Novartis’s P/E?

The share costs about 30.6 years of the company’s earnings (P/E).

What do analysts say about Novartis?

22 analysts on average rate it “hold” with a price target of $152.55 (+0.08% from today). Analyst ratings are opinions, not guarantees. Not investment advice.

How much would I have if I invested $10 a day in Novartis since November 2021?

You would have invested $18,260, and as of November 2026 it would be worth $29,410 (+61.1%). Based on monthly closing prices, before fees and taxes.

Which was better to buy daily over the last 5 years: Novartis or Bitcoin?

$10 a day over the last 5 years would have returned +61.1% for Novartis and +43.3% for Bitcoin. Past performance does not guarantee future results.

Is it worth buying Novartis (NOVN) every day?

Historically, buying Novartis with $10 a day returned +1.71% over the last year and +61.1% over 5 years. Use the calculator above to test other amounts, weekly or monthly purchases and other start dates.

What is DCA (dollar-cost averaging)?

DCA means buying an asset for the same amount at regular intervals, whatever the price. You buy more when it is cheap and less when it is expensive, which smooths volatility and removes the need to time the market.

Similar companies

#NamePrice24h7dMarket capVolume (24h)Last 7 days
1AstraZenecaAZN$175.41−1.87%−4.87%——→
2Merck & Co.MRK$132.81−3.61%−9.62%$327.41 B—→
3AmgenAMGN$438.82−1.14%−6.05%$240.11 B—→
4Gilead SciencesGILD$166.53−1.45%−0.84%$206.55 B—→
5AbbVieABBV$283.54−0.86%−3.71%$505.56 B—→
6PfizerPFE$27.54−1.85%−4.47%$160.61 B—→
7Johnson & JohnsonJNJ$267.14−2.04%−5.78%$643.09 B—→
8Bristol Myers SquibbBMY$58.34−2.05%−6.39%$121.75 B—→

Similar assets: Stock

#NamePrice24h7dMarket capVolume (24h)Last 7 days
1NvidiaNVDA$145.98−3.30%−12.2%$3.52 T—→
2AppleAAPL$349.21−0.92%−1.60%$5.12 T—→
3MicrosoftMSFT$498.30−1.78%−4.54%$3.70 T—→
4Alphabet (Google)GOOG$271.02−2.93%−8.24%$3.33 T—→
5AmazonAMZN$257.37−3.87%−3.77%$2.90 T—→
6MetaMETA$596.22−3.27%−4.39%$1.52 T—→
7TeslaTSLA$374.41−2.43%−5.80%$1.52 T—→
8NetflixNFLX$58.46−2.27%−6.75%$240.06 B—→
9BroadcomAVGO$346.65−2.09%−4.86%$1.69 T—→
10TSMCTSM$352.09−2.90%−13.2%$1.87 T—→
</> Embed · Embed this calculator on your site

This Novartis (NOVN) DCA calculator shows how much you would have made by investing in Novartis regularly — every day, week or month — instead of all at once. It is a free investment calculator for dollar-cost averaging into crypto, stocks and gold.

Follow us
TelegramX (Twitter)BlueskyMediumPinterest✉ support@whatifstack.com🤝 partners@whatifstack.com
Popular
BitcoinEthereumSolanaXRPNvidiaAppleTeslaGoldS&P 500 ETFNasdaq-100 ETF
Markets
MarketsCompareCryptocurrencyStockETFMetalCommodityUnited KingdomCanadaAustraliaUnited StatesUkraine
Tools
CompareConverterLargest companiesFamous investorsLargest assetsMemecoinsBitcoin halvingCalculators
Insights
GuideNewsInsightsRSSActivitiesExchangesAbout & methodologyEditorial policyFor partners & advertisers